Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nanjing Leads Biolabs Co., Ltd. Class H ( (HK:9887) ) has provided an update.
Nanjing Leads Biolabs Co., Ltd., a joint stock company established in China, has announced the full exercise of the Over-allotment Option in its Global Offering. This involves the issuance of 5,529,300 additional shares at HK$35.00 each, representing 15% of the total Offer Shares. The shares will be used to facilitate the delivery of H Shares to certain placees. Approval for listing these shares has been granted, with trading expected to commence on August 11, 2025.
More about Nanjing Leads Biolabs Co., Ltd. Class H
Average Trading Volume: 6,790,328
See more insights into 9887 stock on TipRanks’ Stock Analysis page.